Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Financial Flexibility Index
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Financial Flexibility Index of 0.97x as of September 2025. Free cash flow of CN¥734.52 Million (operating CF CN¥670.83 Million minus capex CN¥63.68 Million) represents 1% of total liabilities (CN¥760.53 Million). Also explore net asset growth rate of Shanghai Allist Pharmaceuticals Co. Ltd. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Allist Pharmaceuticals Co. Ltd. A Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Shanghai Allist Pharmaceuticals Co. Ltd. A across 8 annual periods. Check 688578 financial resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2024)
Year-by-year free cash flow to debt coverage for Shanghai Allist Pharmaceuticals Co. Ltd. A. For the full company profile including market capitalisation, see Shanghai Allist Pharmaceuticals Co. Ltd. (688578) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.90x | CN¥1.84 Billion | CN¥1.57 Billion | CN¥633.32 Million | ▲ +53.9% |
| 2023 | 1.88x | CN¥742.53 Million | CN¥674.65 Million | CN¥394.22 Million | ▲ +104.1% |
| 2022 | 0.92x | CN¥235.46 Million | CN¥91.63 Million | CN¥255.12 Million | ▼ -34.6% |
| 2021 | 1.41x | CN¥221.54 Million | CN¥29.29 Million | CN¥156.99 Million | ▲ +242.0% |
| 2020 | -0.99x | CN¥-108.29 Million | CN¥-196.75 Million | CN¥109.01 Million | ▲ +15.8% |
| 2019 | -1.18x | CN¥-170.01 Million | CN¥-259.37 Million | CN¥144.02 Million | ▼ -485.6% |
| 2018 | -0.20x | CN¥-61.27 Million | CN¥-97.25 Million | CN¥303.96 Million | ▼ -323.1% |
| 2017 | 0.09x | CN¥11.51 Million | CN¥10.11 Million | CN¥127.37 Million | — |